IP Library › Patent Application 19684179
Patent Application Utility
App. No. 19/684,179 · Confirmation No. 7046

METHODS FOR TREATMENT OF CD20-POSITIVE PROLIFERATIVE DISORDER WITH MOSUNETUZUMAB AND POLATUZUMAB VEDOTIN

Applicant: Genentech, Inc.
Application Undergoing Preexam Processing View Publication ↗
⬇ PDF
 Code Description Pages PDF
2026-09-10 NTC.PUB Notice of Publication 1 View
2026-06-04 NTC.MISS.PRT Notice to File Missing Parts 2 View
2026-06-04 WFEE Fee Worksheet (SB06) 1 View
2026-06-04 APP.FILE.REC Filing Receipt 4 View
2026-06-04 WCLM Claims Worksheet (PTO-2022) 2 View
2026-06-04 WELCOME.LET Welcome Letter from USPTO Director and Deputy Director 1 View
2026-06-02 CRFE Sequence Listing in Computer Readable Format, No errors found — View
2026-06-02 CRFE Sequence Listing in Computer Readable Format, No errors found 14 View
2026-05-21 SPEC Specification — View
2026-05-21 DRW Drawings-only black and white line drawings 2 View
2026-05-21 SPEC Specification 82 View
2026-05-21 CLM Claims 10 View
2026-05-21 ABST Abstract 1 View
2026-05-21 PA.. Power of Attorney 2 View
2026-05-21 OATH Oath or Declaration filed 3 View
2026-05-21 TRNA Transmittal of New Application 1 View
2026-05-21 ADS Application Data Sheet 9 View
2026-05-21 N417 Electronic Filing System Acknowledgment Receipt 3 View
2026-05-21 N417.PYMT Electronic Fee Payment 2 View
2026-05-21 SEQ.XML Sequence Listing (XML File) 1 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
19/684,179
Filed
2026-05-21
Pub. No.
US20260265397A1
Art Unit
1645